Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings.
D000293:Adolescent; D000679:Amygdala / Q000187:drug effects / Q000473:pathology*; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D007839:Functional Laterality; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy / Q000473:pathology*; D017374:Paroxetine / Q000627:therapeutic use*; D013997:Time Factors
D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine